Y Intercept (Hong Kong) LTD Moon Lake Immunotherapeutics Transaction History
Y Intercept (Hong Kong) LTD
- $1.44 Billion
- Q4 2024
A detailed history of Y Intercept (Hong Kong) LTD transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Y Intercept (Hong Kong) LTD holds 9,229 shares of MLTX stock, worth $350,978. This represents 0.03% of its overall portfolio holdings.
Number of Shares
9,229
Previous 20,325
54.59%
Holding current value
$350,978
Previous $1.02 Million
52.15%
% of portfolio
0.03%
Previous 0.07%
Shares
4 transactions
Others Institutions Holding MLTX
# of Institutions
137Shares Held
58.1MCall Options Held
124KPut Options Held
96.9K-
Bvf Inc San Francisco, CA19.8MShares$751 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$323 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$127 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$105 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$83.2 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.4B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...